ADIGOG M1 FORTE
Glimepiride 1 mg + Metformin Hydrochloride 1000 mg (PR) tabletA PROMISING THERAPEUTIC OPTION FOR UNCONTROLLED T2DM
Suboptimal glycemic control increases the risk of diabetes complications
For optimum glycemic control
-
A cost-effective & easily accessible approach for managing T2DM
-
Widely used in T2DM patients with comorbidities & diabetic complications
-
Suitable for early as well as long-standing diabetes
-
Significantly better glycemic control than sitagliptin/metformin combination
-
Minimal risk of hypoglycemia & weight gain
-
Once-daily dose exhibited higher patient adherence
Tablet contains:
-
Glimepiride 1 mg + Metformin Hydrochloride 1000 mg (PR) tablet
-
Type 2 diabetes mellitus
-
It's important to follow your doctor's directions when taking medicine
Our Products
